
Vanguard has joined the fight against cancer by providing the market with affordable oncology (tumor), haematological, and supportive care drugs. Most people have had a family member or friend fight cancer and have encountered the tremendous expenses of the procedure. Vanguard's markets in Brazil, Peru, Paraguay, and Cameroon leave its people and governments having to pay thousands of dollars more per patient than is needed. Vanguard is offering their products for at least 70% below the branded equivalent drug and below generic competitors allowing a greater reach to the people who need it the most.
Its line is GMP certified, ISO 9001 certified, and WHO accredited. They are the 7th largest manufacturer of oncology drugs in India and are striving to grow by capturing the largest market share in each market they enter.
SOLID TUMOUR |
||
Capecitabine (Capit) 500mg (12's) |
||
Etoposide (Cytosid) 100mg (5ml) |
||
HAEMATOLOGICAL PRODUCTS |
||
Methotrexate (Amtrex) 50mg (2ml) 500mg (5ml) 1gm (10ml) |
||
SUPPORTIVE CARE |
||
Wheyprotein (Provital) 200g |
Waste Fluid Solidifier (Provital) 50g | |

Telomerase inhibitor combined with radiation therapy works like a
one-two punch
View article
Telomerase Inhibition Plus Doxorubicin Boosts Apoptosis of Breast
Cancer Cells
View article
Latin America Generic Market
View pdf
Milestones in Telomerase Research:
Read Article
Telomerase and the Ageing Process
View pdf
Nanotechnology Cancer Treatment:
Read Article
![]()
Oncology Manufacturer's Presentation: Mac Mohan Pharma
View pdf
Generic Manufacturer's Presentation: Arbro Pharmaceuticals
View pdf
Vanguard's Subsidiaries Presentation
View pdf